TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
CSTL

Castle Biosciences Inc

Healthcare · Diagnostics & Research

35.00$ -1.0% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement CSTL
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
35.8% 23.2% 14.1% 15.5% 16.8% 23.4% 20.5% 18.1% 20.6%
64.2% 76.8% 85.9% 84.5% 83.2% 76.6% 79.5% 81.9% 79.4%
32.5% 21.3% 14.2% 21.2% 31.5% 32.8% 24.4% 15.7% 15.1%
110.9% 72.3% 57.5% 76.8% 92.2% 41.2% 30.3% 23.1% 26.5%
143.5% 93.6% 71.8% 95.0% 125.8% 129.8% 110.5% 79.3% 91.8%
-79.2% -16.8% 14.1% -10.4% -42.6% -53.2% -30.9% 2.6% -12.4%
12.0% 10.0% 8.8% 4.2% 0.0% 0.0% 0.0% 0.2% 0.0%
-89.9% -27.9% 10.3% -16.3% -42.5% -50.3% -26.1% 6.5% -8.6%
0.1% 0.0% 0.1% 0.1% -9.3% -1.3% 0.0% 1.0% -1.6%
-89.9% -27.9% 10.2% -16.4% -33.3% -49.0% -26.1% 5.5% -7.0%
-75.6% -16.5% 19.8% -11.3% -38.9% -42.6% -20.5% 11.5% 3.3%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?